Quantum-Si incorporated (QSI)
| Market Cap | 392.69M |
| Revenue (ttm) | 3.44M |
| Net Income (ttm) | -100.72M |
| Shares Out | 183.50M |
| EPS (ttm) | -0.66 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 12,849,657 |
| Open | 2.040 |
| Previous Close | 1.980 |
| Day's Range | 2.030 - 2.180 |
| 52-Week Range | 0.612 - 5.770 |
| Beta | 2.92 |
| Analysts | Strong Buy |
| Price Target | 2.38 (+11.22%) |
| Earnings Date | Aug 6, 2025 |
About QSI
Quantum-Si incorporated, a life sciences company, engages in the development of single-molecule detection platform to enable Next Generation Protein Sequencing (NGPS). The company offers Platinum NGPS instrument that provides single molecule amino acid level resolution with a streamlined workflow, including automated data analysis that accessible to researchers in all laboratory types; Platinum Pro NGPS instrument, a single molecule amino acid resolution, which provides an enhanced user interface, cloud or on instrument data analysis and an ava... [Read more]
Financial Performance
In 2024, Quantum-Si incorporated's revenue was $3.06 million, an increase of 182.62% compared to the previous year's $1.08 million. Losses were -$101.01 million, 5.26% more than in 2023.
Financial StatementsAnalyst Summary
According to 3 analysts, the average rating for QSI stock is "Strong Buy." The 12-month stock price target is $2.38, which is an increase of 11.22% from the latest price.
News
Quantum-Si Incorporated Announces Pricing of $50 Million Registered Direct Offering of Common Stock
BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si Incorporated Announces Pricing of $50 Million Registered Direct Offering of Common Stock.
Quantum-Si Platinum® Pro Instrument Placed at the Broad Institute to Support Regional Research Initiatives
BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si Platinum® Pro Instrument Placed at the Broad Institute to Support Regional Research Initiatives.
Quantum-Si to Join Leading Experts from DNAnexus, Olink, and Northwestern in Upcoming GenomeWeb Webinar on Proteomics Data Integration and Standardization
BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si to Join Leading Experts from DNAnexus, Olink, & Northwestern in Upcoming GenomeWeb Webinar on Proteomics Data Integration & Standardization.
Quantum-Si Customer to Showcase Protein Barcoding for Nucleic Acid–LNP Therapeutic Development at Festival of Genomics Boston
BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si Customer to Showcase Protein Barcoding for Nucleic Acid–LNP Therapeutic Development at Festival of Genomics Boston.
Quantum-Si Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4).
Quantum-Si's Single-Molecule Tech Enables Precise, Multiplexed Measurement of Nanobody Binding in a Single Assay
BRANFORD, Conn.--(BUSINESS WIRE)--Single-Molecule Tech Enables Precise, Multiplexed Measurement of Nanobody Binding in a Single Assay.
Quantum-Si: Sell On Weak Prospects And Risk Of Further Dilution
After mistakenly having been picked up as a quantum computing play in late 2024, shares of life sciences company, Quantum-Si, have given back most of their gains in recent months. While the company us...
Quantum-Si incorporated (QSI) Q1 2025 Earnings Call Transcript
Quantum-Si incorporated (NASDAQ:QSI) Q1 2025 Earnings Conference Call May 15, 2025 4:30 PM ET Company Participants Jeff Hawkins - President and CEO Jeff Keyes - CFO Conference Call Participants Kyle ...
Quantum-Si Reports First Quarter 2025 Financial Results
BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si Reports First Quarter 2025 Financial Results; Launches & Delivers First Platinum® Pro Units; Announces New Library Prep Development Program.
Dr. Gloria Sheynkman from the University of Virginia to Present Pioneering Research utilizing Quantum-Si's Next-Gen Protein Sequencing™ Platform in Upcoming Nature Webinar on May 15
BRANFORD, Conn.--(BUSINESS WIRE)--Dr. Gloria Sheynkman, University of Virginia, Presents Research utilizing Quantum-Si's Next-Gen Protein Sequencing™ Platform in Nature Webinar on 5/15.
Quantum-Si to Report First Quarter 2025 Financial Results on May 15, 2025
BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si to Report First Quarter 2025 Financial Results on May 15, 2025.
Quantum-Si Begins Shipping Platinum® Pro, Advancing Accessibility in Next-Gen Protein Sequencing™
BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si Begins Shipping Platinum® Pro, Advancing Accessibility in Next-Gen Protein Sequencing™.
Quantum-Si to Participate in DNAnexus Webinar on Large Scale Proteomics in Multi-Omics Research
BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si to participate in DNAnexus webinar on large scale proteomics in multi-omics research.
Quantum-Si: A Rose, By Any Other Name, Wouldn't Smell As Sweet
Quantum-Si aims to revolutionize protein sequencing but faces significant technological and competitive challenges. Commercial reception to Quantum-Si's solutions has been lukewarm so far, suggesting ...
Quantum-Si incorporated (QSI) Q4 2024 Earnings Call Transcript
Quantum-Si incorporated (NASDAQ:QSI) Q4 2024 Earnings Conference Call March 3, 2025 4:30 PM ET Company Participants Katherine Atkins - SVP, Commercial Markets Jeff Hawkins - President and CEO Jeff Ke...
Quantum-Si Reports Fourth Quarter and Full Year 2024 Financial Results
BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si Reports Fourth Quarter and Full Year 2024 Financial Results.
Quantum-Si's Customers and Researchers to Showcase Next-Generation Protein Sequencing™ at AGBT 2025
BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si's Customers and Researchers to Showcase Next-Generation Protein Sequencing™ at AGBT 2025.
Quantum-Si and Researchers to Showcase Next-Generation Protein Sequencing™ at US HUPO 2025
BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si and Researchers to Showcase Next-Generation Protein Sequencing™ at US HUPO 2025.
Quantum-Si to Report Fourth Quarter and Full Year 2024 Financial Results on March 3, 2025
BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si to Report Fourth Quarter and Full Year 2024 Financial Results on March 3, 2025.
Quantum-Si Establishes Scientific Advisory Board to Shape Next-Generation Proteomic Technologies
BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si Establishes Scientific Advisory Board to Shape Next-Generation Proteomic Technologies.
Quantum-Si and IDEX Health & Science to Partner on Optics Module for Proteus™ Instrument
BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si and IDEX Health & Science to Partner on Optics Module for Proteus™ Instrument.
Quantum-Si Showcases Advances in Multiomics at the Festival of Genomics UK
BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si Showcases Advances in Multiomics at the Festival of Genomics UK.
Quantum-Si Launches Platinum® Pro: The End-to-End Solution for Deeper Insights in Proteomics
BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si Launches Platinum® Pro: The End-to-End Solution for Deeper Insights in Proteomics.
Quantum-Si's New Preprint Showcases Protein Barcoding as a Powerful Tool for Transforming Proteomics
BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si's New Preprint Showcases Protein Barcoding as a Powerful Tool for Transforming Proteomics.
Quantum-Si's 327% Rally In Six Months: Is Nvidia The Catalyst For More Gains?
Quantum-Si Inc. QSI is stealing the biotech spotlight with a jaw-dropping 327% surge over the past six months. The proteomics pioneer's stock now sits at $4.10, boasting a strong bullish trend and cat...